About compounded medications
Through Van Peptides, patients may be prescribed compounded medications that are prepared by US-licensed compounding pharmacies specifically for that individual patient based on a valid prescription written by an independent US-licensed provider. These medications are not approved by the U.S. Food and Drug Administration (FDA) and have not been evaluated by the FDA for safety, effectiveness, or quality.
Compounded drugs are customized formulations that may be prescribed when FDA-approved medications are not suitable for a patient's specific needs. While these medications are prepared in accordance with applicable laws and standards, the FDA does not verify or endorse compounded drugs.
Important information
- Compounded medications do not undergo the same premarket review for safety, effectiveness, and quality as FDA-approved drugs
- There may be batch-to-batch variability in potency and purity
- The long-term safety profile of many compounded formulations has not been established through large-scale clinical trials
- Compounded injectable medications must be prepared under strict sterile conditions to prevent contamination
- Dosing instructions must be followed precisely — compounded products may use different concentrations than commercial equivalents
Our pharmacy partners
All compounded medications offered through Van Peptides are prepared by US-licensed compounding pharmacies that adhere to applicable state and federal standards, including USP compounding chapters and state board of pharmacy regulations. The specific pharmacy that fills your prescription will be disclosed on your prescription paperwork and shipment.
503A and 503B pharmacies
Van Peptides works with two categories of US-licensed compounding pharmacies, defined under the Federal Food, Drug, and Cosmetic Act:
- 503A pharmacies are traditional compounding pharmacies licensed and regulated by state boards of pharmacy. They prepare medications on a patient-specific basis in response to a valid prescription from a licensed provider. Compounded preparations from a 503A pharmacy are not FDA-approved and are intended for the individual patient named on the prescription.
- 503B outsourcing facilities are compounding facilities that have voluntarily registered with the FDA and are subject to Current Good Manufacturing Practice (cGMP) requirements. 503B facilities may compound larger batches under stricter oversight, and are periodically inspected by the FDA. Preparations from a 503B facility are also not FDA-approved as finished drug products, but the facility itself is federally registered and inspected.
Depending on the medication, dosage form, and clinical situation, your prescription may be filled by either a 503A or a 503B partner. In both cases the pharmacy is US-licensed, the medication is prepared under USP standards, and the finished compounded medication is not FDA-approved for safety or efficacy. The pharmacy that filled your prescription, its license state, and contact information will appear on the medication label.
Storage and use
Follow the storage and administration instructions provided with your medication. Do not use a compounded medication after its beyond-use date. If you have questions about storage, dosing, or administration, contact your provider.
Adverse events
If you experience an adverse reaction, stop using the medication and contact your provider or seek emergency care as appropriate. You may also report adverse events to the FDA MedWatch program at fda.gov/medwatch.
Disclaimer
The information provided by Van Peptides, including on this website and in communications, is for educational and informational purposes only and should not be considered medical advice. Always consult a licensed healthcare provider before starting or changing any medication or treatment.
Product packaging and appearance may vary from images shown. Individual results vary.
Van Peptides LLC
Email: hello@vanpeptides.com